Inventor · Village of La Jolla, CA, US

Alessandro Sette

43Patents
14h-index
67Co-inventors
84Inventor score

Filing activity: Dec 7, 1987 → Mar 11, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US5736142A Alteration of immune response using pan DR-binding peptides Emerging Cross-Sectional Technologies 120 Expired
US6037135A Methods for making HLA binding peptides and their uses Human Necessities 120 Expired
US5662907A Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes Chemistry; Metallurgy 71 Expired
US5679640A Immunosuppressant peptides Chemistry; Metallurgy 62 Expired
US6534482B1 Expression vectors for stimulating an immune response and methods of using the same Emerging Cross-Sectional Technologies 60 Expired
US6602510B1 HLA class I A2 tumor associated antigen peptides and vaccine compositions Human Necessities 56 Expired
US6419931B1 Compositions and methods for eliciting CTL immunity Chemistry; Metallurgy 39 Expired
US6689363B1 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions Chemistry; Metallurgy 37 Expired
US5750395A DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides Human Necessities 35 Expired
US7026443B1 Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions Chemistry; Metallurgy 32 Expired
US6413935B1 Induction of immune response against desired determinants Chemistry; Metallurgy 32 Expired
US7462354B2 Method and system for optimizing minigenes and peptides encoded thereby Emerging Cross-Sectional Technologies 27 Expired
US5200320A Method for identifying useful polypeptide vaccines Physics 19 Expired
US8741576B2 Heteroclitic analogs and related methods Chemistry; Metallurgy 17 Active
US6464980B1 MAGE-1 c-terminal immunogenic peptides Human Necessities 14 Expired
US9340577B2 HLA binding motifs and peptides and their uses Chemistry; Metallurgy 13 Active
US7202351B1 Alteration of immune response using pan DR-binding peptides Emerging Cross-Sectional Technologies 12 Expired
US6413517B1 Identification of broadly reactive DR restricted epitopes Emerging Cross-Sectional Technologies 12 Expired
US6156316A Oncogene fusion protein peptide vaccines Chemistry; Metallurgy 11 Expired
US8007810B2 HLA-A2 tumor associated antigen peptides and compositions Human Necessities 11 Active
US9913884B2 HLA-A2 tumor associated antigen peptides and compositions Human Necessities 10 Active
US7252829B1 HLA binding peptides and their uses Chemistry; Metallurgy 10 Expired
US7888472B2 Optimized multi-epitope constructs and uses thereof Chemistry; Metallurgy 9 Active
US7572882B2 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions Chemistry; Metallurgy 4 Expired
US9266930B1 Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions Emerging Cross-Sectional Technologies 3 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.